Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.
Rituximab does not reset defective early B cell tolerance checkpoints.
Gene Expression Profiles of Autophagy-Related Genes in Multiple Sclerosis.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
World Congress of Neurology (WCN) 2015
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
Epigenetics of Multiple Sclerosis: An Updated Review.
8th Annual Symposium on Glial-Neuronal Interactions
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Rituximab for relapsing-remitting multiple sclerosis.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.

Pages